ISOAD Become a Member Search
2023
Impact Factor
7.0

Call for papers

Special Issue Title: New Technologies and Advances in Aging and Neurodegenerative Diseases

Deadline: May 31, 2025   

Aging and neurodegenerative diseases are among the most significant healthcare challenges of the 21st century, affecting millions worldwide and placing substantial strain on healthcare systems. As global populations age, the prevalence of conditions such as Alzheimer’s disease, Parkinson’s disease, and other neurodegenerative disorders continues to increase, creating an urgent need for innovative approaches to prevention, diagnosis, and treatment. This special issue, New Technologies and Advances in Aging and Neurodegenerative Diseases, aims to showcase groundbreaking advancements that are transforming our understanding and management of these complex conditions.

 Through this collection, we aim to gather research on transformative technologies that have the potential to reshape the landscape of neurodegenerative disease treatment and improve the quality of life for aging populations. We are particularly interested in the following areas, though submissions are not limited to these topics: applications of Artificial Intelligence (AI), wearable technology and digital health platforms, the microbiota-gut-brain axis, and innovative intervention therapies targeting mitochondrial function, neuroinflammation, and neuroimmunology.

 The editors welcome submissions of Original Research, Reviews, Mini-reviews, Opinion, and Perspective related to this topic. We look forward to your contributions that provide new insights and foster further exploration in this critical area of study.


Guest Editor

Huanxing Su, PhD, Professor

Affiliation: Institute of Chinese Medical Science, University of Macau, Taipa, Macau 999078, China

Email: huanxingsu@um.edu.mo

 

Evandro Fei Fang, PhD, Professor

B103.081 (Building B1, 3rd floor, room 081) Akershus University Hospital, 1478 L?renskog, Emails: evandrofeifang@yahoo.com; e.f.fang@medisin.uio.no


Yiying Zhang, MD, PhD

Assistant Professor of Anesthesia
Department of Anesthesia, Critical Care and Pain Medicine
Massachusetts General Hospital & Harvard Medical School
Email: yzhang37@mgh.harvard.edu



Special Issue: Unveiling the relation between cellular aging, epigenetics, and cancer


Deadline for submission of article: 20 December, 2025

Cellular aging describes the process of deterioration and functional decline in cells as they age. Cellular aging refers to the overall process of aging at the cellular level, encompassing various molecular and physiological changes that occur in cells over time. Aging, a universal and inevitable process, has long been a subject of fascination and scientific inquiry. Emerging evidence suggests that the intricate relationship between aging, epigenetics, and cancer holds the key to unraveling the complexities of this natural phenomenon. Epigenetic modifications, such as DNA methylation and histone modifications, have been recognized as crucial mediators in the aging process, influencing gene expression patterns and cellular function. As individuals age, the epigenome undergoes progressive changes, leading to a multitude of age-associated disorders, including cancer. Importantly, the epigenetic clock, a biological measure of age based on DNA methylation patterns, has emerged as a powerful tool in predicting disease prognosis and tracking the aging process. By understanding the dynamic nature of DNA methylation during aging, researchers have uncovered its potential as a 'prophet' of age-related outcomes, including the risk of developing cancer. Notably, the development of epigenetic drugs that target specific pathways involved in age-related diseases, such as cancer, has sparked hope for novel anti-aging strategies.

This special issue invites the submission of Reviews, Mini-Reviews, Perspectives, and Original Articles that provide novel insights into the relationship between aging, epigenetics, and cancer.

 

Guest Editor:

Prof.UMK, Dr. habil.Dr.med.vet. Pawel Kordowitzki, Dipl. ECAR

University Professor

Department of Basic and Preclinical Sciences

Nicolaus Copernicus University, Torun, Poland

Email: p.kordowitzki@umk.pl



Special Issue: Natural Biomaterials and Advanced Medical Devices in Age-Related Diseases


Deadline for submission of article: April 1, 2025


Natural biomaterials and advanced medical devices play a crucial role in addressing age-related diseases within the field of biomedicine. The development and application of these materials offer expanded options and possibilities for the treatment of conditions associated with aging, including osteoporosis, arthritis, Alzheimer's disease, and others. Natural biomaterials, such as polyesters, proteins, and polysaccharides, are utilized to repair damaged tissues, promote cell regeneration, and develop biosensors for monitoring patients' physiological states, thereby potentially slowing the aging process. Advanced medical devices, such as nano-drug carriers, 3D printing scaffolds and microneedle, facilitate precise drug delivery and minimize side effects. The synergy between the biocompatibility of natural materials and the high efficiency and functionality of advanced materials significantly enhances the prevention and treatment of age-related diseases, consequently improving patients' quality of life. Therefore, understanding the pivotal role of natural biomaterials and novel medical devices in geriatric diseases is essential for developing effective treatments.

This special issue invites the submission of Review, Mini-Review and Opinion that provide novel insights into the use of natural biomaterials and innovative medical devices for the treatment of age-related diseases.


Guest Editor,

Dai-Xu Wei, Ph.D.,

Professor,

School of Medicine, Faculty of Life Sciences and Medicine, Northwest University, Xi’an, 710069, China

Email: daviddxwei@163.com

 

Guest Editor,

Quanbo Ji, Ph.D., M.D.,

Associate Professor,

Department of Orthopaedics, Chinese PLA General Hospital

Beijing, 100853, China

Email: quanbo301@163.com


Special Issue:  Mitochondrial Dysfunction in Aging and Age-related Disorders


Deadline for submission of articles: April 1, 2025


Special Issue Information:

    Alterations in mitochondrial bioenergetics, biogenesis, mitophagy and oxidative stress originating from mitochondria are closely linked to aging and the development of age-related diseases. Age-related diseases are very complex process, and the various factors involved in its aetiology are not yet completely understood. The main theme of this Special Issue centers on exploring mitochondrial dysfunction in aging and the development of age-related diseases and the signaling pathways associated with mitochondrial bioenergetics, biogenesis, mitophagy, and reactive oxygen species generation. Additionally, we aim to stimulate constructive discussions about mitochondria-targeted therapies under development and shed light on the latest advancements in understanding aging and disease mechanisms, biomarkers, and therapies related to neurodegeneration. We are inviting submissions of review, mini-review, commentary, or perspective articles, and novel communications that delve into the molecular mechanisms underlying the significance of mitochondria in neurodegenerative disease processes.

 

Guest Editor

Aida Adlimoghaddam PhD, CRQM

Assistant Professor

Neurology Department, SIU School of Medicine

Springfield, IL, USA

Email: aadlimoghaddam72@siumed.edu     



Special Issue: 'Recent advances in aging-related diseases: Evidence from molecular mechanisms to interventions and therapies

 

Deadline for submission of articles: July 30, 2024

 

Special Issue Information:

Aging is an irreversible pathophysiological process that occurs with a decline in tissue and cell function and a significant increase in the risk of various aging-related diseases, including neurological, cardiovascular, metabolic, and immune system diseases. As aging is one of the major risk factors for most chronic diseases, understanding the aging process is expected to facilitate the identification of therapeutic targets for age-related diseases and the development of suitable pharmacological agents for approved clinical use in the future. Research on aging mechanisms and intervention methods is important in improving human health and increasing lifespan. Currently, great progress has been made in research on the molecular mechanisms of aging, and progress has been made in understanding the biological and genetic mechanisms of the aging process, as well as a deeper understanding of the pathogenesis of aging. However, these findings are still far from being able to delay human aging and reduce the occurrence of aging-related diseases. Considering the aging of the population, anti-aging and healthy aging are undoubtedly important tasks of public health organizations, scientific research units, and drug research development centers. Although there are many challenges to research on aging and aging-related diseases, many questions still need to be addressed. This special issue aims to publish reviews, opinions, commentaries, letters to the editor, and correspondence describing the mechanisms related to pharmacological, non-pharmacological interventions and therapeutic strategies for aging-related diseases. 

 

Guest Editors:

 

Nasrollah Moradikor, Ph.D.

Research Director and Head of Brain Aging and Dementia Group

Center for Neuroscience Research, 0105 Tbilisi

Georgia 

Email: moradikor.nasroallah@yahoo.com

 

Mahdi Esmaeilzadeh, Ph.D.

Head of Cell and Molecular Biology Department

Center for Neuroscience Research, 0105 Tbilisi

Georgia

Email: mehdi_dna@yahoo.com







 






Pubdate:2021-10-18 Viewed: 20152